The Patent Finder

Opko Pharmaceuticals, LLC

Also on record
Records under this name other than the patents Opko Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 10 of 10 · Back to Opko Pharmaceuticals, LLC

PatentTitleStatus Expires Confidence
US 7,872,118Sirna and Methods of Manufacture
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,215,618Articles and Methods Directed to Personalized Therapy of Cancer
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,804,168Biomarker Discovery in Complex Biological Fluid Using Bead or Particle Based Libraries and Diagnostic Kits and Therapeutics
Lapsed on the fee record
Ended Oct 31, 2025 · Medium confidence
Lapsed on the fee recordEnded Oct 31, 2025Medium confidence
US 10,829,509Pure heptasulfated disaccharides having improved oral bioavailability
Lapsed on the fee record
Ended Nov 10, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 10, 2024From the USPTO record
US 8,227,444Compositions and Methods for Inhibition of VEGF
Formerly held
Lapsed on the fee record
Ended Jul 24, 2024 · High confidence
Lapsed on the fee recordEnded Jul 24, 2024High confidence
US 8,202,845Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
Formerly held
Term ended
Ended no later than Apr 16, 2023 · Medium confidence
Term endedEnded no later than Apr 16, 2023Medium confidence
US 8,946,180Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
Formerly held
Lapsed on the fee record
Ended Feb 3, 2023 · High confidence
Lapsed on the fee recordEnded Feb 3, 2023High confidence
US 8,603,756Antigen surrogates in autoimmune disease
Lapsed on the fee record
Ended Dec 10, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 10, 2021From the USPTO record
US 8,470,792Compositions and Methods for Selective Inhibition of VEGF
Formerly held
Lapsed on the fee record
Ended Jun 25, 2021 · High confidence
Lapsed on the fee recordEnded Jun 25, 2021High confidence
US 9,458,199Antigen surrogates in autoimmune disease
Lapsed on the fee record
Ended Oct 4, 2020 · From the USPTO record
Lapsed on the fee recordEnded Oct 4, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited